Complera - Usage, Side Effects, and Precautions

Complera is a once-daily medication used in the treatment of HIV-1 infection in adults. It is a fixed-dose combination tablet containing three antiretroviral drugs – emtricitabine, rilpivirine, and tenofovir disoproxil fumarate – that work together to suppress the HIV virus and improve immune function.
Category
Drug
Where to get
Prescription medication available at pharmacies
Applicable for
Prepared by Shruti Sahoo, reviewed by Dr. Eugene Smith

Complera FAQ


Image credit: cruzverde.com.co

What is Complera ®?

COMPLERA® is a combination of emtricitabine, rilpivirine, and tenofovir disoproxil fumarate. See full Prescribing & Important Safety Information.

Does Complera contain emtricitabine rilpivirine and tenofovir?

Complera contains a combination of emtricitabine, rilpivirine, and tenofovir. Emtricitabine, rilpivirine, and tenofovir are antiviral medicines that prevent human immunodeficiency virus (HIV) from multiplying in your body. HIV causes acquired immunodeficiency syndrome (AIDS).

How many pills are in Complera?

COMPLERA is 3 medicines in 1 pill. It is a combination of emtricitabine, rilpivirine, and tenofovir disoproxil fumarate. View the Patient Information with important warnings. Ask your healthcare provider if COMPLERA is right for you. Learn about financial and insurance support programs for eligible patients.

How is Complera taken?

Complera is taken by mouth as a tablet. Each Complera tablet contains 200 mg of emtricitabine, 25 mg of rilpivirine, and 300 mg of tenofovir DF. The recommended dosage of Complera in adults and children at least 12 years of age who weigh at least 77 pounds (35 kg) is one tablet once daily.

What are the different types of Complera?

FTC / RPV / TDF, emtricitabine / rilpivirine / tenofovir, emtricitabine / rilpivirine hydrochloride / tenofovir disoproxil fumarate What are the most important things to know about Complera? Complera can cause serious, life-threatening side effects.

Complera References

If you want to know more about Complera, consider exploring links below:

Explore Related Topics

How do antiviral agents for HIV contribute to drug resistance?

Examine the mechanisms through which antiviral agents for HIV can lead to drug resistance, and strategies to mitigate this emerging issue in HIV treatment.

What are the key considerations for prescribing antiviral agents for HIV in elderly patients?

Discuss the specific factors that healthcare professionals should consider when prescribing antiviral agents for HIV to elderly patients, including age-related changes in metabolism.

How can healthcare providers adapt to antiviral resistance trends in HIV?

Exchange ideas and strategies on how healthcare providers can adapt to evolving antiviral resistance trends in HIV management. Share practical tips, resources, and collaborative approaches to enhance patient care and clinical outcomes in the face of resistance challenges.